quinoxalines has been researched along with Disbacteriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avihingsanon, A; Cheevadhanarak, S; Chirapongsathorn, S; Chuaypen, N; Jinato, T; Nookaew, I; Tanaka, Y; Tangkijvanich, P | 1 |
| Guo, X; He, S; Li, S; Ran, C; Wang, Q; Zhang, Z; Zhou, Z | 1 |
2 other study(ies) available for quinoxalines and Disbacteriosis
| Article | Year |
|---|---|
Improvement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients With or Without Human Immunodeficiency Virus Coinfection.
Topics: Adult; Aged; Antiviral Agents; Benzofurans; Coinfection; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Dysbiosis; Female; Gastrointestinal Microbiome; Hepacivirus; Hepatitis C; HIV Infections; Humans; Imidazoles; Male; Middle Aged; Quinoxalines; Treatment Outcome; Viral Load | 2021 |
Antibiotic growth promoter olaquindox increases pathogen susceptibility in fish by inducing gut microbiota dysbiosis.
Topics: Animals; Anti-Bacterial Agents; Disease Susceptibility; Dysbiosis; Fish Diseases; Gastrointestinal Microbiome; Growth Substances; Immunity, Innate; Quinoxalines; Reactive Oxygen Species; Zebrafish | 2017 |